Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Phase Ia trial assesses AGS-009 in patients with SLE

July 3, 2012

GABA(A) receptor modulator improves sleep in human model of insomnia

July 2, 2012

Multiple early-stage trials of MLN-9708 presented

July 2, 2012

FAS-specific antibody for arthritis shows promise in first clinical trial

July 2, 2012

First-in-human data presented on PD-1-targeted cancer immunotherapy

July 2, 2012

Preclinical and phase I results presented for MLN-4924

July 2, 2012

Fixed-dose combination drug evaluated in seasonal allergic and chronic rhinitis

July 2, 2012

Vorinostat in combination with bortezomib: Final results from VANTAGE trials

June 29, 2012

Investigators in Israel design new mouse model of familial dysautonomia

June 29, 2012

Epicutaneous patch for peanut allergy safe and effective in patients

June 29, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...